5 Best European Dividend Stocks to Buy Now

4. Novartis AG (NYSE:NVS)

Forward Dividend Yield: 4.37%

Number of Hedge Fund Holders: 22

Novartis AG (NYSE:NVS) is a Basel, Switzerland-based diversified pharmaceutical company with a focus on cardiovascular, hematology, immunology, and solid tumor treatments.

The company is offloading its business divisions to become a pure-play in the biopharma business that is US-focused. CEO Vas Narasimhan has highlighted that Novartis AG (NYSE:NVS) can outperform the current expectations as it has some of the biggest pharmaceutical brands in its portfolio and a few strong candidates in the pipeline. Novartis AG (NYSE:NVS) anticipates sales to compound annually by 4% till 2027 and forecasts core operating income margin to hover around the 40% level.

Novartis AG (NYSE:NVS) also claims that it has the biggest growth potential in the $1 trillion innovative medicines market, with some of its in-market brandings holding power to achieve multi-billion yearly sales, making it one of the best European stocks. Furthermore, Novartis AG’s (NYSE:NVS) dividend yield of 4.37% is also significantly higher compared to the industry average of 2.28%. According to experts, the company is trading at much lower than its fair value of $136.